Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_assertion type Assertion NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_head.
- NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_assertion description "[Throughout the treatment, SNV promoted the expression of the anti-inflammatory cytokine interleukin-10 as well as neurotrophic factors commonly considered as beneficial in amyotrophic lateral sclerosis management (glial derived neuroptrophic factor, insulin like growth factor, brain derived neurotrophic factor).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_provenance.
- NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_assertion evidence source_evidence_literature NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_provenance.
- NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_assertion SIO_000772 25311268 NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_provenance.
- NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_assertion wasDerivedFrom befree-20150227 NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_provenance.
- NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_assertion wasGeneratedBy ECO_0000203 NP1006230.RAvZaFcxHFURSdMlyDaNOdY0icOsjM9Fm9zGvDB9I2uz4130_provenance.